Affinity DataKd: 1.5nMAssay Description:Binding constant for CDK11 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 1.5nMAssay Description:Binding constant for CDK11 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 1.5nMpH: 7.4 T: 2°CAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 8.40nMAssay Description:Binding constant for CDC2L1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 10nMAssay Description:Binding affinity to wild-type partial length human CDK11 (M1 to N360 residues) expressed in bacterial expression system by Kinomescan assayMore data for this Ligand-Target Pair
Affinity DataKd: 10nMAssay Description:Binding affinity to wild-type partial length human CDK11 (M1 to N360 residues) expressed in bacterial expression system by Kinomescan assayMore data for this Ligand-Target Pair
Affinity DataKd: 25nMAssay Description:Binding affinity to partial length wild-type human CDK19 (M1 to N360 residues) expressed in bacterial expression system by KINOMEscan assayMore data for this Ligand-Target Pair
Affinity DataKd: 32nMAssay Description:KINOMEscan (Ambit Biosciences, San Diego, Calif.), a high-throughput method for screening small molecular agents against a large panel of human kinas...More data for this Ligand-Target Pair
Affinity DataKd: 44nMAssay Description:Binding affinity to human CDK19 assessed as dissociation constant by KdELECT Discover assayMore data for this Ligand-Target Pair
Affinity DataKd: 57nMpH: 7.4 T: 2°CAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 57nMAssay Description:Binding constant for CDK11 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 57nMAssay Description:Binding constant for CDK11 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 74nMAssay Description:Binding constant for CDK11 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 74nMpH: 7.4 T: 2°CAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 74nMAssay Description:Binding constant for CDK11 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 87nMAssay Description:Binding constant for CDK11 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 88nMAssay Description:Binding affinity to CDK11 by high-throughput binding assayMore data for this Ligand-Target Pair
Affinity DataKd: 98nMAssay Description:Binding constant for CDC2L1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 98nMpH: 7.4 T: 2°CAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 98nMAssay Description:Binding constant for CDC2L1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 150nMpH: 7.4 T: 2°CAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 150nMAssay Description:Binding constant for CDC2L1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 190nMAssay Description:Binding constant for CDK11 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 190nMAssay Description:Binding constant for CDK11 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 190nMpH: 7.4 T: 2°CAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 200nMAssay Description:Binding constant for CDK11 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 200nMAssay Description:Binding constant for CDK11 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 200nMpH: 7.4 T: 2°CAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 250nMpH: 7.4 T: 2°CAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 250nMAssay Description:Binding affinity to CDK11More data for this Ligand-Target Pair
Affinity DataKd: 250nMAssay Description:Binding constant for CDK11 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 250nMAssay Description:Binding constant for CDK11 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 290nMAssay Description:Binding constant for CDC2L1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 290nMAssay Description:Binding constant for CDC2L1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 290nMpH: 7.4 T: 2°CAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 310nMAssay Description:Binding affinity to wild-type partial length human CDK11 (M1 to N360 residues) expressed in bacterial expression system by Kinomescan assayMore data for this Ligand-Target Pair
Affinity DataKd: 310nMAssay Description:Binding affinity to wild-type partial length human CDK11 (M1 to N360 residues) expressed in bacterial expression system by Kinomescan assayMore data for this Ligand-Target Pair
Affinity DataKd: 370nMAssay Description:Binding affinity to wild type human partial length CDK11 (1 to 360 residues) expressed in bacterial expression system preincubated for 1 hr measured ...More data for this Ligand-Target Pair
Affinity DataKd: 370nMAssay Description:Binding affinity to wild type human partial length CDK11 (1 to 360 residues) expressed in bacterial expression system preincubated for 1 hr measured ...More data for this Ligand-Target Pair
Affinity DataKd: 420nMAssay Description:Binding constant for CDC2L1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 470nMAssay Description:Binding affinity to human CDK11More data for this Ligand-Target Pair
Affinity DataKd: 470nMAssay Description:Binding affinity to human CDK11More data for this Ligand-Target Pair
Affinity DataKd: 640nMAssay Description:Binding constant for CDC2L1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 700nMAssay Description:Binding constant for CDK11 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 760nMAssay Description:Binding constant for CDC2L1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 950nMAssay Description:Binding constant for CDK11 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 950nMpH: 7.4 T: 2°CAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 950nMAssay Description:Binding constant for CDK11 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 1.10E+3nMpH: 7.4 T: 2°CAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 1.10E+3nMAssay Description:Binding constant for CDK11 kinase domainMore data for this Ligand-Target Pair